Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV)
Launched by ESKISEHIR OSMANGAZI UNIVERSITY · Jan 9, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The human papillomavirus (HPV) can cause health problems ranging from warts in the mouth or genital area to cervical, vaginal, vulvar, penile and anal cancers. Some beliefs about diseases or infectious agents have a negative impact on the early diagnosis and treatment of diseases, particularly by increasing the stigmatization effect of sexually transmitted diseases. Features such as the fact that mucosal contact is sufficient for transmission, that infected people can be symptom-free for a long time, that cancer often develops slowly, and that there are similarities with other sexually tran...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Woman
- • Age \>18 years and older
- • Those who agree to participate in the study
- Exclusion Criteria:
- • Age \<18 years
- • Those who not agree to participate in the study
About Eskisehir Osmangazi University
Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odunpazarı, Eskisehir, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported